Alyxis Uhteg, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 230 S Cascade Dr, Springville, NY 14141 Phone: 716-592-3600 |
Sarah A Andrews, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 224 E Main St, Springville, NY 14141 Phone: 716-592-8140 Fax: 716-961-3713 |
Mr. Douglas Evan Tanner, PHYSICIAN ASSISTANT Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 210 E Main St, Springville, NY 14141 Phone: 716-592-3635 |
Mr. Kenneth M Osborn, RPAC Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 210 E Main St, Springville, NY 14141 Phone: 716-592-3614 Fax: 716-592-2929 |
Celestine Szulewski, P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 25 E Main St, Springville, NY 14141 Phone: 716-592-2832 Fax: 716-592-4452 |
Monica K Balon, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 27 Franklin St, Suite 1, Springville, NY 14141 Phone: 716-592-7400 Fax: 716-592-7519 |
Kenneth Dean Richard Dabolt, RPA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 224 E Main St, Springville, NY 14141 Phone: 716-592-8140 |
Martha Andres, RPA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 168 W Main St, Springville, NY 14141 Phone: 716-592-4781 Fax: 716-592-4429 |
Melissa Fanton, RPA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 210 E Main St, Springville, NY 14141 Phone: 716-592-3600 Fax: 716-592-3613 |
News Archive
A single dose of human papillomavirus (HPV) vaccine could be effective for preventing cervical cancer, raising hopes of fighting the disease in Sub-Saharan Africa, a conference has heard.
Experts at the University of Tokyo have identified a new protein in the pathway that leads to Alzheimer's disease. Researchers used the "molecular scissors" of CRISPR/Cas9 to search for new genes related to the neurodegenerative disease.
75 million baby boomers are approaching the age where the disease is tightening its grip on their bones.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
Geneticists have discovered that a gene involved in the modification of ribonucleic acid (RNA) is mutated in a significant proportion of people with a collection of blood cancers called myelodysplastic syndromes.
› Verified 7 days ago